Inclusion and exclusion criteria Rationale for the inclusion of studies in the present meta-analytical review was to assess the effects of increased GLP-1 levels in blood on atheroscelortic markers in T2D patients
In a 48-week Phase 2 trial published in 2023, Retatrutide produced some dramatic weight loss results
This is distinct from the appetite-suppressing effect of GLP-1 and GIP
Dermoscopy revealed background brown pigmentation (indicated by red arrow), parallel lines (by purple arrows), circular lines (by blue arrows), and overlapping vessels (by orange arrows)
Body Composition (General): Research in non-HIV populations exists, examining effects on visceral fat in obese individuals and potential applications in metabolic syndrome
In this article, well explore the common and uncommon reasons behind night sweats, how they relate to your overall health, and what steps you can take to address them